Clinical Trial Detail

NCT ID NCT00338377
Title Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

melanoma

Therapies

Cyclophosphamide + Fludarabine

Aldesleukin

Age Groups: adult child

No variant requirements are available.